Eleva UCITS Fund - Fonds Eleva European Selection H3 EUR accRegister to Unlock Ratings |
Performance History | 30/11/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | -6.1 | 13.7 | 6.9 | |
+/-Cat | - | - | 2.2 | 2.1 | 3.9 | |
+/-B’mrk | - | - | -1.6 | 0.5 | 1.9 | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
NAV 20/12/2024 | EUR 122.14 | |
Day Change | -0.74% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
ISIN | LU1920211387 | |
Fund Size (Mil) 20/12/2024 | EUR 6484.89 | |
Share Class Size (Mil) 20/12/2024 | EUR 0.39 | |
Max Initial Charge | 3.00% | |
Ongoing Charge 04/12/2024 | 1.60% |
Investment Objective: Eleva UCITS Fund - Fonds Eleva European Selection H3 EUR acc |
The Fund seeks to achieve superior long-term risk adjusted returns and capital growth by investing primarily in European equities and equity related securities. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Armand d’Albufera 26/01/2015 | ||
Eric Bendahan 26/01/2015 | ||
Inception Date 10/08/2021 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
STOXX Europe 600 NR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Eleva UCITS Fund - Fonds Eleva European Selection H3 EUR acc | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk AS Class B | Healthcare | 4.62 |
SAP SE | Technology | 3.06 |
Schneider Electric SE | Industrials | 2.92 |
Intesa Sanpaolo | Financial Services | 2.83 |
Sanofi SA | Healthcare | 2.59 |
Increase Decrease New since last portfolio | ||
Eleva UCITS Fund - Fonds Eleva European Selection H3 EUR acc |